The Utility of Comorbidity Indices in Assessing Head and Neck Surgery Outcomes: A Systematic Review
Kavya Pai BS
University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, U.S.A.
Search for more papers by this authorCarla Baaklini BS
Northeast Ohio Medical University, Rootstown, Ohio, U.S.A.
Search for more papers by this authorClaudia I. Cabrera MD, MS
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Case Medical Center, Cleveland, Ohio, U.S.A.
Case Western Reserve University School of Medicine, Cleveland, Ohio, U.S.A.
Search for more papers by this authorAkina Tamaki MD
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Case Medical Center, Cleveland, Ohio, U.S.A.
Case Western Reserve University School of Medicine, Cleveland, Ohio, U.S.A.
Search for more papers by this authorNicole Fowler MD
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Case Medical Center, Cleveland, Ohio, U.S.A.
Case Western Reserve University School of Medicine, Cleveland, Ohio, U.S.A.
Search for more papers by this authorCorresponding Author
Nicole Maronian MD
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Case Medical Center, Cleveland, Ohio, U.S.A.
Case Western Reserve University School of Medicine, Cleveland, Ohio, U.S.A.
Send correspondence to Nicole Maronian, MD, Department Chair of Otolaryngology-Head and Neck Surgery, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, LKS 5045, Cleveland, OH 44106. E-mail: [email protected]
Search for more papers by this authorKavya Pai BS
University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, U.S.A.
Search for more papers by this authorCarla Baaklini BS
Northeast Ohio Medical University, Rootstown, Ohio, U.S.A.
Search for more papers by this authorClaudia I. Cabrera MD, MS
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Case Medical Center, Cleveland, Ohio, U.S.A.
Case Western Reserve University School of Medicine, Cleveland, Ohio, U.S.A.
Search for more papers by this authorAkina Tamaki MD
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Case Medical Center, Cleveland, Ohio, U.S.A.
Case Western Reserve University School of Medicine, Cleveland, Ohio, U.S.A.
Search for more papers by this authorNicole Fowler MD
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Case Medical Center, Cleveland, Ohio, U.S.A.
Case Western Reserve University School of Medicine, Cleveland, Ohio, U.S.A.
Search for more papers by this authorCorresponding Author
Nicole Maronian MD
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Case Medical Center, Cleveland, Ohio, U.S.A.
Case Western Reserve University School of Medicine, Cleveland, Ohio, U.S.A.
Send correspondence to Nicole Maronian, MD, Department Chair of Otolaryngology-Head and Neck Surgery, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, LKS 5045, Cleveland, OH 44106. E-mail: [email protected]
Search for more papers by this authorEditor's Note: This Manuscript was accepted for publication on October 06, 2021.
The authors have no funding, financial relationships, or conflicts of interest to disclose.
Abstract
Objective
To evaluate the utility of comorbidity index (CI) scores in predicting outcomes in head and neck surgery (HNS). The CIs evaluated were the Charlson Comorbidity Index (CCI), Elixhauser Comorbidity Index (ECI), Kaplan-Feinstein Index (KFI), American Society of Anesthesiologists Physical Status (ASA-PS), Adult Comorbidity Evaluation-27 (ACE-27), National Cancer Institute Comorbidity Index (NCI-CI), and the Washington University Head and Neck Comorbidity Index (WUHNCI).
Methods
We report a systematic review according to the 2009 Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Electronic databases (PubMed, Cochrane, and Embase) and manual search of bibliographies identified manuscripts addressing how CI scores related to HNS outcomes.
Results
A total of 116 studies associated CI scores with HNS outcomes. CIs were represented in the literature as follows: ASA-PS (70/116), CCI (39/116), ACE-27 (24/116), KFI (7/116), NCI-CI (3/116), ECI (2/116), and WUHNCI (1/116). The most frequently cited justification for calculating each CI (if provided) was: CCI for its validation in other studies, ACE-27 for its utility in cancer patients, and ECI for its comprehensive design. In general, the CCI and ACE-27 were predictive of mortality in HNS. The ECI was most consistent in predicting >1-year mortality. The ACE-27 and KFI were most consistent in predicting medical complications.
Conclusion
Despite inconsistencies in the literature, CIs provide insights into the impact of comorbidities on outcomes in HNS. These scores should be employed as an adjunct in the preoperative assessment of HNS patients. Comparative studies are needed to identify indices that are most reliable in predicting HNS outcomes.
Level of Evidence
NA Laryngoscope, 132:1388–1402, 2022
Supporting Information
Filename | Description |
---|---|
lary29905-sup-0001-Tables.docxWord 2007 document , 221.7 KB | Supporting Table 1 Search strategy with Boolean operators. Supporting Table 2. Quality of evidence and risk of bias of each included article. |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
BIBLIOGRAPHY
- 1Mowery A, Light T, Clayburgh D. Long-term trends in head and neck surgery outcomes. Otolaryngol Head and Neck Surgery 2018; 159: 1012–1019.
- 2Farwell DG, Reilly DF, Weymuller EA Jr, Greenberg DL, Staiger TO, Futran NA. Predictors of perioperative complications in head and neck patients. Arch Otolaryngol Head Neck Surg 2002; 128: 505–511.
- 3Jelinek MJ, Howard AS, Haraf DJ, Vokes EE. Management of early head and neck cancer in elderly patients. J Oncol Pract 2018; 14: 541–546.
- 4Genden EM, Rinaldo A, Shaha AR, et al. Treatment considerations for head and neck cancer in the elderly. J Laryngol Otol 2005; 119: 169–174.
- 5Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG, Coman WB. Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 2006; 6: 1111–1118.
- 6Eytan DF, Blackford AL, Eisele DW, Fakhry C. Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States. Cancer 2019; 125: 249–260.
- 7Landis SH, El-Hariry IA, van Herk-Sukel MP, et al. Prevalence and incidence of acute and chronic comorbidity in patients with squamous cell carcinoma of the head and neck. Head Neck 2012; 34: 238–244.
- 8Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope 2000; 110: 593–602.
- 9Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62: e1–e34.
- 10Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 2003; 73: 712–716.
- 11Sanabria A, Carvalho AL, Vartanian JG, Magrin J, Ikeda MK, Kowalski LP. Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol 2007; 14: 1449–1457.
- 12Borggreven PA, Kuik DJ, Quak JJ, de Bree R, Snow GB, Leemans CR. Comorbid condition as a prognostic factor for complications in major surgery of the oral cavity and oropharynx with microvascular soft tissue reconstruction. Head Neck 2003; 25: 808–815.
- 13Borggreven PA, Kuik DJ, Langendijk JA, Doornaert P, de Bree R, Leemans CR. Severe comorbidity negatively influences prognosis in patients with oral and oropharyngeal cancer after surgical treatment with microvascular reconstruction. Oral Oncol 2005; 41: 358–364.
- 14Moore EJ, Van Abel KM, Price DL, et al. Transoral robotic surgery for oropharyngeal carcinoma: surgical margins and oncologic outcomes. Head Neck 2018; 40: 747–755.
- 15Omura G, Ando M, Saito Y, Kobayashi K, Yamasoba T, Asakage T. Comorbidity as predictor poor prognosis for patients with advanced head and neck cancer treated with major surgery. Head Neck 2016; 38: 364–369.
- 16Dimovska EO, Clibbon JJ, Moncrieff MD, Heaton MJ, Figus A. Microsurgical reconstructions for head and neck cancers in elderly aged >80 years: an analysis of surgical outcomes and quality of life. Ann Surg Oncol 2016; 23: 1684–1692.
- 17Peters TT, Post SF, van Dijk BA, et al. Free flap reconstruction for head and neck cancer can be safely performed in both young and elderly patients after careful patient selection. Eur Arch Oto-rhino-laryngol 2015; 272: 2999–3005.
- 18Sindhar S, Kallogjeri D, Wildes TS, Avidan MS, Piccirillo JF. Association of preoperative functional performance with outcomes after surgical treatment of head and neck cancer: a clinical severity staging system. JAMA Otolaryngol Head Neck Surg 2019; 145: 1128–1136.
- 19Bras L, Peters TT, Wedman J, et al. Predictive value of the Groningen frailty indicator for treatment outcomes in elderly patients after head and neck, or skin cancer surgery in a retrospective cohort. Clin Otolaryngol 2015; 40: 474–482.
- 20Homma A, Sakashita T, Oridate N, et al. Importance of comorbidity in hypopharyngeal cancer. Head Neck 2010; 32: 148–153.
- 21Okuyemi OT, Piccirillo JF, Spitznagel E. TNM staging compared with a new clinicopathological model in predicting oral tongue squamous cell carcinoma survival. Head Neck 2014; 36: 1481–1489.
- 22Peters TT, Langendijk JA, Plaat BE, et al. Co-morbidity and treatment outcomes of elderly pharyngeal cancer patients: a matched control study. Oral Oncol 2011; 47: 1159–1164.
- 23van Brederode TD, Halmos GB, Stenekes MW. Functional outcome after one-stage flap reconstruction of the hypopharynx following tumor ablation. Eur Arch Oto-Rhino-Laryngol 2017; 274: 969–976.
- 24Baumeister P, Rauch J, Jacobi C, et al. Impact of comorbidity and anemia in patients with oropharyngeal cancer primarily treated with surgery in the human papillomavirus era. Head Neck 2017; 39: 7–16.
- 25Ferrier MB, Spuesens EB, Le Cessie S, Baatenburg de Jong RJ. Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Arch Otolaryngol Head Neck Surg 2005; 131: 27–32.
- 26Grammatica A, Piazza C, Pellini R, et al. Free flaps for advanced Oral cancer in the "older Old" and "oldest Old": a retrospective multi-institutional study. Front Oncol 2019; 9: 604.
- 27Reiter M, Baumeister P, Jacobi C. Head and neck reconstruction in the elderly patient: a safe procedure? Eur Arch Oto-Rhino-Laryngol 2017; 274: 3169–3174.
- 28Datema FR, Poldermans D, Baatenburg de Jong RJ. Incidence and prediction of major cardiovascular complications in head and neck surgery. Head Neck 2010; 32: 1485–1493.
- 29de la Garza G, Militsakh O, Panwar A, et al. Obesity and perioperative complications in head and neck free tissue reconstruction. Head Neck 2016; 38: E1188–E1191.
- 30L'Esperance HE, Kallogjeri D, Yousaf S, Piccirillo JF, Rich JT. Prediction of mortality and morbidity in head and neck cancer patients 80 years of age and older undergoing surgery. Laryngoscope 2018; 128: 871–877.
- 31Fancy T, Huang AT, Kass JI, et al. Complications, mortality, and functional decline in patients 80 years or older undergoing major head and neck ablation and reconstruction. JAMA Otolaryngol Head Neck Surg 2019; 145: 1150–1157.
- 32Boruk M, Chernobilsky B, Rosenfeld RM, Har-El G. Age as a prognostic factor for complications of major head and neck surgery. Arch Otolaryngol Head Neck Surg 2005; 131: 605–609.
- 33Kamizono K, Sakuraba M, Nagamatsu S, Miyamoto S, Hayashi R. Statistical analysis of surgical site infection after head and neck reconstructive surgery. Ann Surg Oncol 2014; 21: 1700–1705.
- 34Weed HG, Lutman CV, Young DC, Schuller DE. Preoperative identification of patients at risk for delirium after major head and neck cancer surgery. Laryngoscope 1995; 105: 1066–1068.
- 35Pelczar BT, Weed HG, Schuller DE, Young DC, Reilley TE. Identifying high-risk patients before head and neck oncologic surgery. Arch Otolaryngol Head Neck Surg 1993; 119: 861–864.
- 36Penel N, Fournier C, Lefebvre D, Lefebvre JL. Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery with opening of mucosa. Study of 260 surgical procedures. Oral Oncol 2005; 41: 294–303.
- 37Abt NB, Puram SV, Sinha S, et al. Transfusion in head and neck cancer patients undergoing Pedicled flap reconstruction. Laryngoscope 2018; 128: E409–e415.
- 38Klein HJ, Fuchs N, Mehra T, et al. Extending the limits of reconstructive microsurgery in elderly patients. J Plast Reconstr Aesthet Surg 2016; 69: 1017–1023.
- 39Buitelaar DR, Balm AJ, Antonini N, van Tinteren H, Huitink JM. Cardiovascular and respiratory complications after major head and neck surgery. Head Neck 2006; 28: 595–602.
- 40Chen XF, Chen YM, Gokavarapu S, Shen QC, Ji T. Free flap reconstruction for patients aged 85 years and over with head and neck cancer: clinical considerations for comprehensive care. Br J Oral Maxillofac Surg 2017; 55: 793–797.
- 41Hatcher JL, Bell EB, Browne JD, Waltonen JD. Disposition of elderly patients after head and neck reconstruction. JAMA Otolaryngol Head Neck Surg 2013; 139: 1236–1241.
- 42Ogihara H, Takeuchi K, Majima Y. Risk factors of postoperative infection in head and neck surgery. Auris Nasus Larynx 2009; 36: 457–460.
- 43Penel N, Mallet Y, Roussel-Delvallez M, Lefebvre JL, Yazdanpanah Y. Factors determining length of the postoperative hospital stay after major head and neck cancer surgery. Oral Oncol 2008; 44: 555–562.
- 44Small LT, Lampkin M, Vural E, Moreno MA. American Society of Anesthesiologists Class as predictor for perioperative morbidity in head and neck free flaps. Otolaryngol Head Neck Surg 2019; 161: 91–97.
- 45Sturgis EM, Congdon DJ, Mather FJ, Miller RH. Perioperative transfusion, postoperative infection, and recurrence of head and neck cancer. South Med J 1997; 90: 1217–1224.
- 46Suh JD, Sercarz JA, Abemayor E, et al. Analysis of outcome and complications in 400 cases of microvascular head and neck reconstruction. Arch Otolaryngol Head Neck Surg 2004; 130: 962–966.
- 47Yarlagadda BB, Deschler DG, Rich DL, et al. Head and neck free flap surgical site infections in the era of the surgical care improvement project. Head Neck 2016; 38: E392–E398.
- 48Kowalski LP, Alcantara PS, Magrin J, Parise JO. A case-control study on complications and survival in elderly patients undergoing major head and neck surgery. Am J Surg 1994; 168: 485–490.
- 49Azmy MC, Pinto J, Patel NM, Govindan A, Kalyoussef E. Risk factors for blood transfusion with neck dissection. Otolaryngol Head Neck Surg 2019; 161: 922–928.
- 50Broome M, Juilland N, Litzistorf Y, et al. Factors influencing the incidence of severe complications in head and neck free flap reconstructions. Plast Reconstr Surg Glob Open 2016; 4: e1013–e1013.
- 51Cramer JD, Patel UA, Samant S, Shintani SS. Discharge destination after head and neck surgery: predictors of discharge to Postacute care. Otolaryngol Head Neck Surg 2016; 155: 997–1004.
- 52Garg RK, Wieland AM, Hartig GK, Poore SO. Risk factors for unplanned readmission following head and neck microvascular reconstruction: results from the National Surgical Quality Improvement Program, 2011-2014. Microsurgery 2017; 37: 502–508.
- 53Lindeborg MM, Puram SV, Sethi RKV, et al. Predictive factors for prolonged operative time in head and neck patients undergoing free flap reconstruction. Am J Otolaryngol 2020; 41:102392.
- 54Sanabria A, Carvalho AL, Melo RL, et al. Predictive factors for complications in elderly patients who underwent head and neck oncologic surgery. Head Neck 2008; 30: 170–177.
- 55Abt NB, Richmon JD, Koch WM, Eisele DW, Agrawal N. Assessment of the predictive value of the modified frailty index for Clavien-Dindo grade IV critical care complications in major head and neck cancer operations. JAMA Otolaryngol Head Neck Surg 2016; 142: 658–664.
- 56Adams P, Ghanem T, Stachler R, Hall F, Velanovich V, Rubinfeld I. Frailty as a predictor of morbidity and mortality in inpatient head and neck surgery. JAMA Otolaryngol Head Neck Surg 2013; 139: 783–789.
- 57Bollig CA, Spradling CS, Dooley LM, Galloway TL, Jorgensen JB. Impact of perioperative hyperglycemia in patients undergoing microvascular reconstruction. Head Neck 2018; 40: 1196–1206.
- 58BuSaba NY, Schaumberg DA. Predictors of prolonged length of stay after major elective head and neck surgery. Laryngoscope 2007; 117: 1756–1763.
- 59Carniol ET, Marchiano E, Brady JS, et al. Head and neck microvascular free flap reconstruction: an analysis of unplanned readmissions. Laryngoscope 2017; 127: 325–330.
- 60Chen MM, Roman SA, Sosa JA, Judson BL. Safety of adult tonsillectomy: a population-level analysis of 5968 patients. JAMA Otolaryngol Head Neck Surg 2014; 140: 197–202.
- 61Damian D, Esquenazi J, Duvvuri U, Johnson JT, Sakai T. Incidence, outcome, and risk factors for postoperative pulmonary complications in head and neck cancer surgery patients with free flap reconstructions. J Clin Anesth 2016; 28: 12–18.
- 62Ferrari S, Copelli C, Bianchi B, et al. Free flaps in elderly patients: outcomes and complications in head and neck reconstruction after oncological resection. J Cranio-Maxillo-Facial Surg 2013; 41: 167–171.
- 63Karakida K, Sakamoto H, Aoki T, et al. Analysis of risk factors for surgical-site infections in 276 oral cancer surgeries with microvascular free-flap reconstructions at a single university hospital. J Infect Chemother 2010; 16: 334–339.
- 64Kim BD, Ver Halen JP, Lim S, Kim JY. Predictors of 61 unplanned readmission cases in microvascular free tissue transfer patients: multi-institutional analysis of 774 patients. Microsurgery 2015; 35: 13–20.
- 65Kwok AC, Agarwal JP. Unplanned reoperations after microvascular free tissue transfer: an analysis of 2,244 patients using the american college of surgeons national surgical quality improvement program database. Microsurgery 2017; 37: 184–189.
- 66Lee DH, Kim SY, Nam SY, Choi SH, Choi JW, Roh JL. Risk factors of surgical site infection in patients undergoing major oncological surgery for head and neck cancer. Oral Oncol 2011; 47: 528–531.
- 67Liu Z, Tian Z, Zhang C, Sun J, Zhang Z, He Y. Microvascular reconstruction in elderly oral cancer patients: does diabetes status have a predictive role in free flap complications? J Oral Maxillofac Surg 2015; 73: 357–369.
- 68Mays AC, Worley M, Ackall F, D'Agostino R Jr, Waltonen JD. The association between gastrostomy tube placement, poor post-operative outcomes, and hospital re-admissions in head and neck cancer patients. Surg Oncol 2015; 24: 248–257.
- 69Rogers SN, Brown JS, Woolgar JA, et al. Survival following primary surgery for oral cancer. Oral Oncol 2009; 45: 201–211.
- 70Sanati-Mehrizy P, Massenburg BB, Rozehnal JM, Ingargiola MJ, Hernandez Rosa J, Taub PJ. Risk factors leading to free flap failure: analysis from the National Surgical Quality Improvement Program Database. J Craniofac Surg 2016; 27: 1956–1964.
- 71Shaari CM, Urken ML. Complications of head and neck surgery in the elderly. Ear Nose Throat J 1999; 78: 510–512.
- 72Tarsitano A, Pizzigallo A, Sgarzani R, Oranges CM, Cipriani R, Marchetti C. Head and neck cancer in elderly patients: is microsurgical free-tissue transfer a safe procedure? Acta Otorhinolaryngol Ital 2012; 32: 371–375.
- 73White LJ, Zhang H, Strickland KF, et al. Factors associated with hospital length of stay following fibular free-tissue reconstruction of head and neck defects: assessment using the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) criteria. JAMA Otolaryngol Head Neck Surg 2015; 141: 1052–1058.
- 74Yeung JK, Harrop R, McCreary O, et al. Delayed mobilization after microsurgical reconstruction: an independent risk factor for pneumonia. Laryngoscope 2013; 123: 2996–3000.
- 75Osborn HA, Rathi VK, Tjoa T, et al. Risk factors for thirty-day readmission following flap reconstruction of oncologic defects of the head and neck. Laryngoscope 2018; 128: 343–349.
- 76Su HK, Ozbek U, Likhterov I, et al. Safety of transoral surgery for oropharyngeal malignancies: an analysis of the ACS NSQIP. Laryngoscope 2016; 126: 2484–2491.
- 77Serletti JM, Higgins JP, Moran S, Orlando GS. Factors affecting outcome in free-tissue transfer in the elderly. Plast Reconstr Surg 2000; 106: 66–70.
- 78McMahon JD, MacIver C, Smith M, et al. Postoperative complications after major head and neck surgery with free flap repair—prevalence, patterns, and determinants: a prospective cohort study. Br J Oral Maxillofac Surg 2013; 51: 689–695.
- 79Tadiparthi S, Enache A, Kalidindi K, O'Hara J, Paleri V. Hospital stay following complex major head and neck resection: what factors play a role? Clin Otolaryngol 2014; 39: 156–163.
- 80Clark JR, McCluskey SA, Hall F, et al. Predictors of morbidity following free flap reconstruction for cancer of the head and neck. Head Neck 2007; 29: 1090–1101.
- 81Abu-Ghanem S, Warshavsky A, Carmel NN, et al. Predictive factors for perioperative blood transfusion in neck dissection. Laryngoscope 2016; 126: 851–857.
- 82Reid BC, Alberg AJ, Klassen AC, Koch WM, Samet JM. The American Society of Anesthesiologists' class as a comorbidity index in a cohort of head and neck cancer surgical patients. Head Neck 2001; 23: 985–994.
- 83Ettinger KS, Arce K, Lohse CM, et al. Higher perioperative fluid administration is associated with increased rates of complications following head and neck microvascular reconstruction with fibular free flaps. Microsurgery 2017; 37: 128–136.
- 84Howard MA, Cordeiro PG, Disa J, et al. Free tissue transfer in the elderly: incidence of perioperative complications following microsurgical reconstruction of 197 septuagenarians and octogenarians. Plast Reconstr Surg 2005; 116: 1659–1668. discussion 1669-1671.
- 85Lee JI, Kwon M, Roh JL, et al. Postoperative hypoalbuminemia as a risk factor for surgical site infection after oral cancer surgery. Oral Dis 2015; 21: 178–184.
- 86Yoo SH, Roh JL, Choi SH, Nam SY, Kim SY. Incidence and risk factors for morbidity and mortality in elderly head and neck cancer patients undergoing major oncological surgery. J Cancer Res Clin Oncol 2016; 142: 1343–1351.
- 87Parsemain A, Philouze P, Pradat P, Ceruse P, Fuchsmann C. Free flap head and neck reconstruction: feasibility in older patients. J Geriatr Oncol 2019; 10: 577–583.
- 88Lotfi CJ, Cavalcanti RD, Silva AM, et al. Risk factors for surgical-site infections in head and neck cancer surgery. Otolaryngol Head Neck Surg 2008; 138: 74–80.
- 89de Cássia Braga Ribeiro K, Kowalski LP, Latorre Mdo R. Perioperative complications, comorbidities, and survival in oral or oropharyngeal cancer. Arch Otolaryngol Head Neck Surg 2003; 129: 219–228.
- 90Patel RS, McCluskey SA, Goldstein DP, et al. Clinicopathologic and therapeutic risk factors for perioperative complications and prolonged hospital stay in free flap reconstruction of the head and neck. Head Neck 2010; 32: 1345–1353.
- 91Eskander A, Kang S, Tweel B, et al. Predictors of complications in patients receiving head and neck free flap reconstructive procedures. Otolaryngol Head Neck Surg 2018; 158: 839–847.
- 92Eskander A, Kang SY, Tweel B, et al. Quality indicators: measurement and predictors in head and neck cancer free flap patients. Otolaryngol Head Neck Surg 2018; 158: 265–272.
- 93Isaac A, Zhang H, Varshney S, et al. Predictors of failed and delayed decannulation after head and neck surgery. Otolaryngol Head Neck Surg 2016; 155: 437–442.
- 94Kim J, Kim S, Albergotti WG, et al. Selection of ideal candidates for surgical salvage of head and neck squamous cell carcinoma: effect of the Charlson-age comorbidity index and oncologic characteristics on 1-year survival and hospital course. JAMA Otolaryngol Head Neck Surg 2015; 141: 1059–1065.
- 95Lang DM, Danan D, Sawhney R, et al. Discharge delay in head and neck free flap surgery: risk factors and strategies to minimize hospital days. Otolaryngol Head Neck Surg 2019; 160: 829–838.
- 96Shah S, Har-El G, Rosenfeld RM. Short-term and long-term quality of life after neck dissection. Head Neck 2001; 23: 954–961.
- 97Singh B, Cordeiro PG, Santamaria E, Shaha AR, Pfister DG, Shah JP. Factors associated with complications in microvascular reconstruction of head and neck defects. Plast Reconstr Surg 1999; 103: 403–411.
- 98Zenga J, Suko J, Kallogjeri D, Pipkorn P, Nussenbaum B, Jackson RS. Postoperative hemorrhage and hospital revisit after transoral robotic surgery. Laryngoscope 2017; 127: 2287–2292.
- 99Baskin RM, Zhang J, Dirain C, et al. Predictors of returns to the emergency department after head and neck surgery. Head Neck 2018; 40: 498–511.
- 100Bukatko AR, Patel PB, Kakarla V, et al. All-cause 30-Day mortality after surgical treatment for head and neck squamous cell carcinoma in the United States. Am J Clin Oncol 2019; 42: 596–601.
- 101Luryi AL, Chen MM, Mehra S, Roman SA, Sosa JA, Judson BL. Hospital readmission and 30-day mortality after surgery for oral cavity cancer: analysis of 21,681 cases. Head Neck 2016; 38: E221–E226.
- 102Zhan KY, Graboyes EM, Nguyen SA, Day TA. Risk factors associated with unplanned readmission in patients undergoing parotid cancer surgery: a study of the National Cancer Database. JAMA Otolaryngol Head Neck Surg 2016; 142: 544–550.
- 103Chaudhary H, Stewart CM, Webster K, et al. Readmission following primary surgery for larynx and oropharynx cancer in the elderly. Laryngoscope 2017; 127: 631–641.
- 104Dziegielewski PT, Boyce B, Manning A, et al. Predictors and costs of readmissions at an academic head and neck surgery service. Head Neck 2016; 38: E502–E510.
- 105Graboyes EM, Yang Z, Kallogjeri D, Diaz JA, Nussenbaum B. Patients undergoing total laryngectomy: an at-risk population for 30-day unplanned readmission. JAMA Otolaryngol Head Neck Surg 2014; 140: 1157–1165.
- 106Lee CC, Ho HC, Chou P. Multivariate analyses to assess the effect of surgeon volume on survival rate in oral cancer: a nationwide population-based study in Taiwan. Oral Oncol 2010; 46: 271–275.
- 107Luryi AL, Chen MM, Mehra S, Roman SA, Sosa JA, Judson BL. Positive surgical margins in early stage oral cavity cancer: an analysis of 20,602 cases. Otolaryngol Head Neck Surg 2014; 151: 984–990.
- 108Nouraei SA, Middleton SE, Hudovsky A, et al. A national analysis of the outcome of major head and neck cancer surgery: implications for surgeon-level data publication. Clin Otolaryngol 2013; 38: 502–511.
- 109Reid BC, Alberg AJ, Klassen AC, et al. Comorbidity and survival of elderly head and neck carcinoma patients. Cancer 2001; 92: 2109–2116.
10.1002/1097-0142(20011015)92:8<2109::AID-CNCR1552>3.0.CO;2-M CAS PubMed Web of Science® Google Scholar
- 110Varadarajan VV, Sawhney R, Bernard SH, et al. Improving quality outcomes in head and neck free flap surgery with the use of a physician inpatient coordinator. Laryngoscope 2018; 128: 336–342.
- 111Al-Qurayshi Z, Walsh J, Owen S, Kandil E. Surgical site infection in head and neck surgery: a National Perspective. Otolaryngol Head Neck Surg 2019; 161: 52–62.
- 112Bøje CR, Dalton SO, Primdahl H, et al. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database. Radiother Oncol 2014; 110: 91–97.
- 113Alho OP, Hannula K, Luokkala A, Teppo H, Koivunen P, Kantola S. Differential prognostic impact of comorbidity in head and neck cancer. Head Neck 2007; 29: 913–918.
- 114Bhama PK, Patel SA, Khan U, Bhrany AD, Futran ND. Head and neck free flap reconstruction in patients older than 80 years. J Reconstr Microsurg 2014; 30: 523–530.
- 115Park SY, Kim MS, Eom JS, Lee JS, Rho YS. Risk factors and etiology of surgical site infection after radical neck dissection in patients with head and neck cancer. Korean J Intern Med 2016; 31: 162–169.
- 116Chang HJ, Chen PC, Yang CC, Su YC, Lee CC. Comparison of Elixhauser and Charlson methods for predicting Oral cancer survival. Medicine 2016; 95:e2861.
- 117Lee CC, Ho HC, Su YC, Chen PC, Yu CH, Yang CC. Comparison of different comorbidity measures for oral cancer patients with surgical intervention: a longitudinal study from a single cancer center. Auris Nasus Larynx 2016; 43: 322–329.
- 118Ribeiro KCB, Kowalski LP, Latorre MRDO. Impact of comorbidity, symptoms, and patients' characteristics on the prognosis of oral carcinomas. Arch Otolaryngol Head Neck Surg 2000; 126: 1079–1085.
- 119Pierre CS, Dassonville O, Chamorey E, et al. Long-term functional outcomes and quality of life after oncologic surgery and microvascular reconstruction in patients with oral or oropharyngeal cancer. Acta Otolaryngol 2014; 134: 1086–1093.
- 120Benatar MJ, Dassonville O, Chamorey E, et al. Impact of preoperative radiotherapy on head and neck free flap reconstruction: a report on 429 cases. J Plast Reconstr Aesthet Surg 2013; 66: 478–482.
- 121Haughey BH, Wilson E, Kluwe L, et al. Free flap reconstruction of the head and neck: analysis of 241 cases. Otolaryngol Head Neck Surg 2001; 125: 10–17.
- 122Lacy PD, Piccirillo JF, Merritt MG, Zequeira MR. Head and neck squamous cell carcinoma: better to be young. Otolaryngol Head Neck Surg 2000; 122: 253–258.
- 123Nao EE, Dassonville O, Chamorey E, et al. Head and neck free-flap reconstruction in the elderly. Eur Ann Otorhinolaryngol Head Neck Dis 2011; 128: 47–51.
- 124Shah MD, Goldstein DP, McCluskey SA, et al. Blood transfusion prediction in patients undergoing major head and neck surgery with free-flap reconstruction. Arch Otolaryngol Head Neck Surg 2010; 136: 1199–1204.
- 125Dooley BJ, Karassawa Zanoni D, McGill MR, et al. Intraoperative and postanesthesia care unit fluid administration as risk factors for postoperative complications in patients with head and neck cancer undergoing free tissue transfer. Head Neck 2020; 42: 14–24.
- 126Piccirillo JF, Lacy PD, Basu A, Spitznagel EL. Development of a new head and neck cancer–specific comorbidity index. Arch Otolaryngol Head Neck Surg 2002; 128: 1172–1179.
- 127Hall SF, Groome PA, Streiner DL, Rochon PA. Interrater reliability of measurements of comorbid illness should be reported. J Clin Epidemiol 2006; 59: 926–933.
- 128Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 1974; 27: 387–404.
- 129Singh B, Bhaya M, Stern J, et al. Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study. Laryngoscope 1997; 107: 1469–1475.
- 130Sinha P, Kallogjeri D, Piccirillo JF. Assessment of comorbidities in surgical oncology outcomes. J Surg Oncol 2014; 110: 629–635.